Downregulation of HLA class I expression by c-myc in human melanoma is independent of enhancer A.

AUTOR(ES)

Peltenburg, L T

RESUMO

High constitutive expression of the c-myc oncogene in human melanoma leads to downregulation of expression of HLA Class I genes. The genes at the HLA-B locus are preferentially affected. To investigate the mechanism of downregulation, the activity of the main HLA Class I enhancer, enhancer A-region I, was compared in a panel of c-myc transfectants with increasing myc expression. Gel retardation experiments demonstrated in all tested cell lines binding of the transcription factors KBF1 and NF-kappa B to the enhancer. However, no correlation between the levels of HLA Class I expression and binding to the enhancer could be established. Strikingly, the cell line with the highest c-myc expression showed more binding of KBF1 and NF-kappa B than the parental cell line. By using CAT reporter plasmids in transient transfection assays we investigated the in vivo function of enhancer A-region I in the c-myc transfectant panel. Again, c-myc expression had no effect at all on the activity of enhancer A. This study shows that HLA Class I expression is regulated by the c-myc oncogene at the level of transcription, but that the main HLA Class I enhancer is not involved in this process.

Documentos Relacionados

• c-myc down-regulates class I HLA expression in human melanomas.
• Novel promoter upstream of the human c-myc gene and regulation of c-myc expression in B-cell lymphomas.
• DNA replication origin and transcriptional enhancer in c-myc gene share the c-myc protein binding sequences.
• c-Myc protein expression is not an independent prognostic predictor in cervical squamous cell carcinoma
• Serum-inducible expression of transfected human c-myc genes.